The controversy behind the company emerged as a result of the drugs that they made and how they carried high potential for abuse by drug abusers, and people with a history of addiction.
When Oxycontin was released in 1996, it was marketed as having lower abuse potential than immediate-release oxycodone because of its time-release properties even though there was no scientific evidence backing that conclusion [REF].